WHO Labels Monkeypox Latest “Global Health Emergency” – Reveals Vaccinated Are Merely Part of Massive “Clinical Trial!”

The World Health Organization (WHO) has declared monkeypox a global health emergency with the organization’s leader claiming the virus is spreading “rapidly through new modes of transmission,” while admitting that those who take the vaccine for it are part of a “clinical trial.”

There’s a lot to unpack here. First off, the WHO panel did not have a consensus on labeling the sickness a global health emergency. WHO leader Dr. Tedros Adhanom Ghebreyesus directed the organization to declare it a “public health emergency of international concern” after the other voting members didn’t vote his way.

“We have an outbreak that has spread around the world rapidly through new modes of transmission, about which we understand too little, and which meets the criteria” Tedros told the press.

With the declaration, monkeypox joins COVID and polio as the other diseases designated as international emergencies by the global health organization.

After a WHO panel did not unanimously vote the way Tedros wanted, he made the decision to elevate the threat level on his own, adding that the process of declaring an emergency needs to be redesigned.

“This process demonstrates once again that this vital tool needs to be sharpened to make it more effective,” he said.

Another frightening thing about this is the “vaccine” being used to treat the infected. The Biden administration has ordered hundreds of thousands of doses of a vaccine used to protect against the disease – but according to the WHO itself, those vaccines are untested and could therefore be dangerous to recipients.

The health organization admitted that everyone who gets the monkeypox vaccine is part of a clinical trial to gauge whether the shot is effective.

WHO’s chief of infectious hazards preparedness agency Tim Nguyen noted that the monkeypox vaccine’s efficacy isn’t known because it’s never been used on a large scale.

“I would like to underline one thing that is very important to WHO. We do have uncertainty around the effectiveness of these vaccines because they haven’t been used in this context and in this scale before,” Nguyen noted.

Nguyen added that “when these vaccines are being delivered, that they are delivered in the context of clinical trial studies and prospectively collecting this data to increase our understanding of the effectiveness of these vaccines.”

New York City announced it had purchased thousands of doses of JYNNEOS vaccines last week, one of the two FDA-licensed vaccines. The other is called ACAM2000, also known as Imvamune or Imvanex.

“The NY Health Department announced plans for its next allocation of the JYNNEOS vaccine,” the New York City Health Department said in a statement on July 21. “Approximately 26,000 additional doses were delivered to New York City as part of Phase 2b from the federal government and state, and will be distributed via clinics, mass vaccination sites and community-based referrals. Individuals will be able to book appointments for July 24 through August 13.”

While the experimental COVID jabs were similarly untested, at least there were clinical trials completed ahead of releasing it on the masses,  it appears as though global leaders are subjecting the masses to these experiments are growing more emboldened and no longer bothering to even hide the fact that they simply don’t know what will happen if you’re injected with these vaccines.